NJ State Employees Deferred Compensation Plan - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 102 filers reported holding ARATANA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$568,000
+125.4%
110,000
+57.1%
0.10%
+121.7%
Q1 2019$252,000
+37.0%
70,000
+133.3%
0.05%
+21.1%
Q4 2018$184,000
-82.0%
30,000
-82.9%
0.04%
-78.2%
Q3 2018$1,022,000
+33.6%
175,000
-2.8%
0.17%
+27.0%
Q2 2018$765,000
+2.0%
180,000
+5.9%
0.14%
+2.2%
Q1 2018$750,000
+1.9%
170,000
+21.4%
0.13%
+5.5%
Q4 2017$736,000140,0000.13%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
March Altus Capital Management LP 218,515$1,219,00011.21%
Broadfin Capital, LLC 3,428,865$19,133,0001.18%
MPM ASSET MANAGEMENT LLC 1,117,875$6,238,0001.11%
AlpInvest Partners B.V. 100,001$558,0000.93%
First Light Asset Management, LLC 395,043$2,204,0000.92%
Westend Capital Management, LLC 89,780$501,0000.69%
Grandeur Peak Global Advisors, LLC 460,675$2,571,0000.53%
AWM Investment Company, Inc. 467,507$2,609,0000.51%
HAMILTON LANE ADVISORS LLC 111,705$623,0000.27%
Sio Capital Management, LLC 97,376$543,0000.24%
View complete list of ARATANA THERAPEUTICS INC shareholders